Download
-+ 0.00%
-+ 0.00%
-+ 0.00%
BICO Q3 operating loss narrows 78% year-on-year to SEK 236.3 million; Q3 net sales rise 20% year-on-year to SEK 465.2 million
Share
Listen to the news
BICO Q3 operating loss narrows 78% year-on-year to SEK 236.3 million; Q3 net sales rise 20% year-on-year to SEK 465.2 million
  • BICO Group’s Q3 2026 net loss from continuing operations narrowed 80% year over year to SEK 220.4 million.
  • Net sales rose 20% year over year to SEK 465.2 million.
  • A noncash impairment of SEK 295.6 million covered Biosero’s remaining goodwill and technology, following weaker performance and a strategic shift.
  • The new BICO 2030 strategy prioritizes Precision Biology, reducing exposure to large, customized lab automation projects.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BICO Group AB published the original content used to generate this news brief on November 11, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending